Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis

Identifieur interne : 003531 ( Main/Merge ); précédent : 003530; suivant : 003532

Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis

Auteurs : Orwa Dandash [Australie] ; Ben J. Harrison [Australie] ; Ram Adapa [Royaume-Uni] ; Raphael Gaillard [France] ; Francesco Giorlando [Australie] ; Stephen J. Wood [Australie, Royaume-Uni] ; Paul C. Fletcher [Royaume-Uni] ; Alex Fornito [Australie]

Source :

RBID : PMC:4246009

Descripteurs français

English descriptors

Abstract

The psychotomimetic effect of the N-methyl-D-aspartate receptor (NMDAR) antagonist ketamine is thought to arise from a functional modulation of the brain's fronto-striato-thalamic (FST) circuits. Animal models suggest a pronounced effect on ventral ‘limbic' FST systems, although recent work in patients with psychosis and high-risk individuals suggests specific alterations of dorsal ‘associative' FST circuits. Here, we used functional magnetic resonance imaging to investigate the effects of a subanesthetic dose of ketamine on measures of functional connectivity as indexed by the temporal coherence of spontaneous neural activity in both dorsal and ventral FST circuits, as well as their symptom correlates. We adopted a placebo-controlled, double-blind, randomized, repeated-measures design in which 19 healthy participants received either an intravenous saline infusion or a racemic mixture of ketamine (100 ng/ml) separated by at least 1 week. Compared with placebo, ketamine increased functional connectivity between the dorsal caudate and both the thalamus and midbrain bilaterally. Ketamine additionally increased functional connectivity of the ventral striatum/nucleus accumbens and ventromedial prefrontal cortex. Both connectivity increases significantly correlated with the psychosis-like and dissociative symptoms under ketamine. Importantly, dorsal caudate connectivity with the ventrolateral thalamus and subthalamic nucleus showed inverse correlation with ketamine-induced symptomatology, pointing to a possible resilience role to disturbances in FST circuits. Although consistent with the role of FST in mediating psychosis, these findings contrast with previous research in clinical samples by suggesting that acute NMDAR antagonism may lead to psychosis-like experiences via a mechanism that is distinct from that implicated in frank psychotic illness.


Url:
DOI: 10.1038/npp.2014.210
PubMed: 25141922
PubMed Central: 4246009

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4246009

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis</title>
<author>
<name sortKey="Dandash, Orwa" sort="Dandash, Orwa" uniqKey="Dandash O" first="Orwa" last="Dandash">Orwa Dandash</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Monash Clinical and Imaging Neuroscience Laboratory, School of Psychology and Psychiatry, Monash University</institution>
, Clayton, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Harrison, Ben J" sort="Harrison, Ben J" uniqKey="Harrison B" first="Ben J" last="Harrison">Ben J. Harrison</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Adapa, Ram" sort="Adapa, Ram" uniqKey="Adapa R" first="Ram" last="Adapa">Ram Adapa</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Division of Anaesthesia, University of Cambridge</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Addenbrooke's Hospital</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, Raphael" sort="Gaillard, Raphael" uniqKey="Gaillard R" first="Raphael" last="Gaillard">Raphael Gaillard</name>
<affiliation wicri:level="1">
<nlm:aff id="aff5">
<institution>Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff6">
<institution>Centre Hospitalier Sainte-Anne, Department of Psychiatry, Service Hospitalo-Universitaire</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff7">
<institution>INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences, UMR S894</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Giorlando, Francesco" sort="Giorlando, Francesco" uniqKey="Giorlando F" first="Francesco" last="Giorlando">Francesco Giorlando</name>
<affiliation wicri:level="1">
<nlm:aff id="aff8">
<institution>Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wood, Stephen J" sort="Wood, Stephen J" uniqKey="Wood S" first="Stephen J" last="Wood">Stephen J. Wood</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff9">
<institution>School of Psychology, University of Birmingham</institution>
, Birmingham,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fletcher, Paul C" sort="Fletcher, Paul C" uniqKey="Fletcher P" first="Paul C" last="Fletcher">Paul C. Fletcher</name>
<affiliation wicri:level="1">
<nlm:aff id="aff10">
<institution>Department of Psychiatry, Brain Mapping Unit and Behavioural and Clinical Neurosciences Institute, School of Clinical Medicine, University of Cambridge</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fornito, Alex" sort="Fornito, Alex" uniqKey="Fornito A" first="Alex" last="Fornito">Alex Fornito</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Monash Clinical and Imaging Neuroscience Laboratory, School of Psychology and Psychiatry, Monash University</institution>
, Clayton, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25141922</idno>
<idno type="pmc">4246009</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246009</idno>
<idno type="RBID">PMC:4246009</idno>
<idno type="doi">10.1038/npp.2014.210</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000074</idno>
<idno type="wicri:Area/Pmc/Curation">000074</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000074</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001346</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001346</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="wicri:Area/PubMed/Corpus">003079</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003079</idno>
<idno type="wicri:Area/PubMed/Curation">002F98</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F98</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F98</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002F98</idno>
<idno type="wicri:Area/Ncbi/Merge">001D29</idno>
<idno type="wicri:Area/Ncbi/Curation">001D29</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D29</idno>
<idno type="wicri:doubleKey">0893-133X:2014:Dandash O:selective:augmentation:of</idno>
<idno type="wicri:Area/Main/Merge">003531</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis</title>
<author>
<name sortKey="Dandash, Orwa" sort="Dandash, Orwa" uniqKey="Dandash O" first="Orwa" last="Dandash">Orwa Dandash</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Monash Clinical and Imaging Neuroscience Laboratory, School of Psychology and Psychiatry, Monash University</institution>
, Clayton, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Harrison, Ben J" sort="Harrison, Ben J" uniqKey="Harrison B" first="Ben J" last="Harrison">Ben J. Harrison</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Adapa, Ram" sort="Adapa, Ram" uniqKey="Adapa R" first="Ram" last="Adapa">Ram Adapa</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Division of Anaesthesia, University of Cambridge</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Addenbrooke's Hospital</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Gaillard, Raphael" sort="Gaillard, Raphael" uniqKey="Gaillard R" first="Raphael" last="Gaillard">Raphael Gaillard</name>
<affiliation wicri:level="1">
<nlm:aff id="aff5">
<institution>Université Paris Descartes, Sorbonne Paris Cité, INSERM UMR S894</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff6">
<institution>Centre Hospitalier Sainte-Anne, Department of Psychiatry, Service Hospitalo-Universitaire</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff7">
<institution>INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences, UMR S894</institution>
, Paris,
<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Giorlando, Francesco" sort="Giorlando, Francesco" uniqKey="Giorlando F" first="Francesco" last="Giorlando">Francesco Giorlando</name>
<affiliation wicri:level="1">
<nlm:aff id="aff8">
<institution>Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wood, Stephen J" sort="Wood, Stephen J" uniqKey="Wood S" first="Stephen J" last="Wood">Stephen J. Wood</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff9">
<institution>School of Psychology, University of Birmingham</institution>
, Birmingham,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fletcher, Paul C" sort="Fletcher, Paul C" uniqKey="Fletcher P" first="Paul C" last="Fletcher">Paul C. Fletcher</name>
<affiliation wicri:level="1">
<nlm:aff id="aff10">
<institution>Department of Psychiatry, Brain Mapping Unit and Behavioural and Clinical Neurosciences Institute, School of Clinical Medicine, University of Cambridge</institution>
, Cambridge,
<country>UK</country>
</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Fornito, Alex" sort="Fornito, Alex" uniqKey="Fornito A" first="Alex" last="Fornito">Alex Fornito</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne</institution>
, Melbourne, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Monash Clinical and Imaging Neuroscience Laboratory, School of Psychology and Psychiatry, Monash University</institution>
, Clayton, VIC,
<country>Australia</country>
</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Neuropsychopharmacology</title>
<idno type="ISSN">0893-133X</idno>
<idno type="eISSN">1740-634X</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Corpus Striatum (drug effects)</term>
<term>Corpus Striatum (physiology)</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Frontal Lobe (drug effects)</term>
<term>Frontal Lobe (physiology)</term>
<term>Functional Neuroimaging</term>
<term>Humans</term>
<term>Ketamine (pharmacology)</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Mesencephalon (drug effects)</term>
<term>Mesencephalon (physiology)</term>
<term>Neural Pathways (drug effects)</term>
<term>Neural Pathways (physiology)</term>
<term>Nucleus Accumbens (drug effects)</term>
<term>Nucleus Accumbens (physiology)</term>
<term>Prefrontal Cortex (drug effects)</term>
<term>Psychoses, Substance-Induced (physiopathology)</term>
<term>Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)</term>
<term>Thalamus (drug effects)</term>
<term>Thalamus (physiology)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Corps strié ()</term>
<term>Corps strié (physiologie)</term>
<term>Cortex préfrontal ()</term>
<term>Femelle</term>
<term>Humains</term>
<term>Imagerie par résonance magnétique</term>
<term>Jeune adulte</term>
<term>Kétamine (pharmacologie)</term>
<term>Lobe frontal ()</term>
<term>Lobe frontal (physiologie)</term>
<term>Mâle</term>
<term>Mésencéphale ()</term>
<term>Mésencéphale (physiologie)</term>
<term>Méthode en double aveugle</term>
<term>Neuroimagerie fonctionnelle</term>
<term>Noyau accumbens ()</term>
<term>Noyau accumbens (physiologie)</term>
<term>Psychoses toxiques (physiopathologie)</term>
<term>Récepteurs du N-méthyl-D-aspartate (antagonistes et inhibiteurs)</term>
<term>Thalamus ()</term>
<term>Thalamus (physiologie)</term>
<term>Voies nerveuses ()</term>
<term>Voies nerveuses (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Receptors, N-Methyl-D-Aspartate</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Ketamine</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Récepteurs du N-méthyl-D-aspartate</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Corpus Striatum</term>
<term>Frontal Lobe</term>
<term>Mesencephalon</term>
<term>Neural Pathways</term>
<term>Nucleus Accumbens</term>
<term>Prefrontal Cortex</term>
<term>Thalamus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Kétamine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Corps strié</term>
<term>Lobe frontal</term>
<term>Mésencéphale</term>
<term>Noyau accumbens</term>
<term>Thalamus</term>
<term>Voies nerveuses</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Corpus Striatum</term>
<term>Frontal Lobe</term>
<term>Mesencephalon</term>
<term>Neural Pathways</term>
<term>Nucleus Accumbens</term>
<term>Thalamus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Psychoses toxiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Psychoses, Substance-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Double-Blind Method</term>
<term>Female</term>
<term>Functional Neuroimaging</term>
<term>Humans</term>
<term>Magnetic Resonance Imaging</term>
<term>Male</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Corps strié</term>
<term>Cortex préfrontal</term>
<term>Femelle</term>
<term>Humains</term>
<term>Imagerie par résonance magnétique</term>
<term>Jeune adulte</term>
<term>Lobe frontal</term>
<term>Mâle</term>
<term>Mésencéphale</term>
<term>Méthode en double aveugle</term>
<term>Neuroimagerie fonctionnelle</term>
<term>Noyau accumbens</term>
<term>Thalamus</term>
<term>Voies nerveuses</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The psychotomimetic effect of the
<italic>N</italic>
-methyl-
<sc>D</sc>
-aspartate receptor (NMDAR) antagonist ketamine is thought to arise from a functional modulation of the brain's fronto-striato-thalamic (FST) circuits. Animal models suggest a pronounced effect on ventral ‘limbic' FST systems, although recent work in patients with psychosis and high-risk individuals suggests specific alterations of dorsal ‘associative' FST circuits. Here, we used functional magnetic resonance imaging to investigate the effects of a subanesthetic dose of ketamine on measures of functional connectivity as indexed by the temporal coherence of spontaneous neural activity in both dorsal and ventral FST circuits, as well as their symptom correlates. We adopted a placebo-controlled, double-blind, randomized, repeated-measures design in which 19 healthy participants received either an intravenous saline infusion or a racemic mixture of ketamine (100 ng/ml) separated by at least 1 week. Compared with placebo, ketamine increased functional connectivity between the dorsal caudate and both the thalamus and midbrain bilaterally. Ketamine additionally increased functional connectivity of the ventral striatum/nucleus accumbens and ventromedial prefrontal cortex. Both connectivity increases significantly correlated with the psychosis-like and dissociative symptoms under ketamine. Importantly, dorsal caudate connectivity with the ventrolateral thalamus and subthalamic nucleus showed inverse correlation with ketamine-induced symptomatology, pointing to a possible resilience role to disturbances in FST circuits. Although consistent with the role of FST in mediating psychosis, these findings contrast with previous research in clinical samples by suggesting that acute NMDAR antagonism may lead to psychosis-like experiences via a mechanism that is distinct from that implicated in frank psychotic illness.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003531 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003531 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     PMC:4246009
   |texte=   Selective Augmentation of Striatal Functional Connectivity Following NMDA Receptor Antagonism: Implications for Psychosis
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:25141922" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024